Table 2.
Characteristics of control subjects.
| ID# | Age years | Sex | BDNF ng/ml | ProBDNF ng/ml | IGF1 ng/ml |
|---|---|---|---|---|---|
| C1 | 5 | F | 34.74 | 8.70 | 103.39 |
| C2 | 5 | M | 38.07 | 14.56 | 71.43 |
| C3 | 5 | M | 40.37 | 13.82 | 106.83 |
| C4 | 5 | M | 43.35 | 10.94 | 84.8 |
| C5 | 5 | M | 47.36 | 12.37 | 96.39 |
| C6 | 6 | M | 7.14 | 13.94 | 65.71 |
| C8 | 6 | M | 43.33 | 13.43 | 157.61 |
| C11 | 6 | M | 42.96 | 11.50 | 95.24 |
| C12 | 7 | M | 45.47 | 10.65 | 124.53 |
| C13 | 7 | F | 38.1 | 8.23 | 108.7 |
| C14 | 7 | F | 42.27 | 17.48 | 123.03 |
| C15 | 7 | M | 27.95 | 17.48 | 113.51 |
| C16 | 8 | M | 9.38 | 17.01 | 58.53 |
| C17 | 9 | M | 35.56 | 14.90 | 89.44 |
| C18 | 9 | M | 35.37 | 15.52 | 85.62 |
| C19 | 9 | F | 34.04 | 13.95 | 107.17 |
| C20 | 9 | M | 41.17 | 30.56§ | 127.78 |
| C21 | 10 | M | 30.73 | 14.55 | 103.2 |
| C22 | 10 | M | 34.63 | 17.32 | 53.63 |
| C23 | 11 | M | 38.05 | 15.22 | 272.04 |
| C24 | 11 | M | 26.56 | 19.85 | 47.52 |
| C25 | 11 | M | 20.58 | nd | 46.63 |
| C26 | 11 | F | 27.01 | 19.36 | 50.32 |
| C27 | 11 | F | 21.35 | 16.28 | 230.54 |
| C28 | 11 | F | 36.47 | 17.01 | 115.41 |
| C29 | 12 | M | 25.1 | 16.53 | 141.43 |
| C30 | 13 | M | 26.41 | 17.40 | 144.11 |
| C32 | 14 | F | 43.08 | 11.09 | 100.22 |
| C33 | 14 | M | 35.5 | 16.31 | 250.52 |
| Mean | 8.68 | M = 21 | 33.99 | 15.21 | 115.31 |
| SEM ± | 0.54 | F = 8 | 1.87 | 0.80 | 10.53 |
| Median | 9.00 | 35.53 | 15.06 | 105.11 |
M male, F female, BDNF brain-derived neurotrophic factor, IGF-1 insulin-like growth factor 1, §outlier detected by Grubb’s test, nd not determined.